Loading...
XNAS
IRTC
Market cap4.34bUSD
Jul 11, Last price  
135.94USD
1D
0.91%
1Q
33.16%
Jan 2017
353.13%
IPO
427.10%
Name

iRhythm Technologies Inc

Chart & Performance

D1W1MN
XNAS:IRTC chart
No data to show
P/E
—
P/S
7.33
EPS
—
Div Yield, %
—
Shrs. gr., 5y
4.31%
Rev. gr., 5y
22.50%
Revenues
592m
+20.13%
15,368,00021,749,00036,140,00064,072,00098,509,000147,293,000214,552,000265,166,000322,825,000410,921,000492,681,000591,839,000
Net income
-113m
L-8.20%
-13,589,000-15,832,000-22,799,000-20,903,000-29,420,000-48,280,000-54,568,000-43,830,000-101,361,000-116,155,000-123,406,000-113,289,000
CFO
3m
P
-11,849,000-15,626,000-18,005,000-16,651,000-14,911,000-29,068,000-21,863,000-13,759,000-37,753,000-23,012,000-50,101,0003,390,000
Earnings
Jul 30, 2025

Profile

iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
URL
https://www.irhythmtech.com/
IPO date
Oct 20, 2016
Employees
1,793
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
591,839
20.13%
492,681
19.90%
410,921
27.29%
Cost of revenue
288,138
221,119
175,899
Unusual Expense (Income)
NOPBT
303,701
271,562
235,022
NOPBT Margin
51.31%
55.12%
57.19%
Operating Taxes
565
750
269
Tax Rate
0.19%
0.28%
0.11%
NOPAT
303,136
270,812
234,753
Net income
(113,289)
-8.20%
(123,406)
6.24%
(116,155)
14.60%
Dividends
Dividend yield
Proceeds from repurchase of equity
(25,000)
8,820
13,182
BB yield
0.89%
-0.27%
-0.47%
Debt
Debt current
15,867
30,318
13,031
Long-term debt
811,508
209,539
214,110
Deferred revenue
Other long-term liabilities
8,579
1,012
1,307
Net debt
229,920
103,093
13,997
Cash flow
Cash from operating activities
3,390
(50,101)
(23,012)
CAPEX
(40,424)
(29,830)
Cash from investing activities
(122,983)
(1,209)
(52,434)
Cash from financing activities
511,381
8,820
26,716
FCF
287,563
230,844
240,295
Balance
Cash
535,553
133,764
213,144
Long term investments
61,902
3,000
Excess cash
567,863
112,130
192,598
Stockholders' equity
(758,699)
(645,687)
(522,568)
Invested Capital
1,595,095
1,001,779
892,337
ROIC
23.35%
28.60%
27.68%
ROCE
36.31%
76.26%
63.56%
EV
Common stock shares outstanding
31,196
30,528
29,916
Price
90.17
-15.76%
107.04
14.27%
93.67
-20.41%
Market cap
2,812,943
-13.92%
3,267,717
16.61%
2,802,205
-18.82%
EV
3,042,863
3,370,810
2,816,202
EBITDA
303,701
293,706
254,631
EV/EBITDA
10.02
11.48
11.06
Interest
12,821
3,650
4,138
Interest/NOPBT
4.22%
1.34%
1.76%